DIH Holding US (DHAI) Registration Filing summary

Company overview and business model

• Global provider of advanced robotic and VR-enabled devices for physical rehabilitation, serving hospitals, clinics, and research centers, with a focus on restoring mobility and enhancing human performance.

• Revenue is concentrated in Europe, Middle East, Africa, and the Americas, with a growing presence in Asia Pacific.

• Business model includes device sales, services, and technology integration, targeting inpatient, outpatient, and research markets.

• Strategy centers on innovation, market consolidation, and expanding leadership through acquisitions and organic growth.

Financial performance and metrics

• Fiscal year ended March 31, 2024 revenue was $64.5 million, up 19.3% from $54.1 million in 2023.

• Net loss for fiscal 2024 was $8.4 million, compared to $1.0 million in 2023, primarily due to transaction costs and increased cost of goods sold.

• Gross profit for 2024 was $29.8 million, with a gross margin decline due to higher input costs and inventory reserves.

• As of June 30, 2024, cash and cash equivalents were $2.7 million, with an accumulated deficit of $35.8 million.

• Operating losses have persisted since 2020, but management expects to fund growth through operations and future financings.

Use of proceeds and capital allocation

• No proceeds will be received from the resale of shares by selling stockholders; proceeds from warrant exercises (if any) will be used for general corporate and working capital purposes.

• Up to $153.4 million could be raised from warrant exercises, but current stock price is below exercise price, making near-term exercises unlikely.

• Recent $3.3 million convertible debt issuance in June 2024, with proceeds used to strengthen liquidity.